Automating the Breast Radiation Therapy Process to Improve Efficiency
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Female
Breast Cancer
Female
Breast Cancer
Trial Information
Automating the Breast Radiation Therapy Process to Improve Efficiency
Inclusion Criteria:
- Patients with breast cancer who will receive standard two-field tangential whole
breast radiation therapy with dose prescription of 4240 cGy in 16 fractions, 5000 cGy
in 25 fractions or 4000 cGy in 16 fractions.
- Patients with any stage of breast cancer.
- Patients with prior treatment such as surgery or chemotherapy for any type of cancer.
- Able to provide a written informed consent.
- 18 years of age or older.
Exclusion Criteria:
- < 18 years of age.
- Unable to provide informed consent.
- Males.
- Patients who received partial breast radiation and not the standard dose.
- Patients who will not receive 4240 cGy in 16 fractions, 5000 cGy in 25 fractions, or
4000 cGy in 16 fractions.
Type of Study:
Interventional
Study Design:
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
To generate on-line IMRT treatment plans using automated tools based on CBCT images acquired at the treatment unit.
Outcome Time Frame:
3 years
Safety Issue:
No
Principal Investigator
Robert Dinniwell, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University Health Network, Princess Margaret Hospital
Authority:
Canada: Ethics Review Committee
Study ID:
UHN REB 09-0197-CE
NCT ID:
NCT00923871
Start Date:
June 2009
Completion Date:
June 2014
Related Keywords:
- Breast Cancer
- CBCT
- Breast Cancer
- Breast Neoplasms
Name | Location |
|---|
